Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicenter, Randomized Controlled Trial Designed to Evaluate the Efficacy and Safety of Adjuvant Hyperthermic Intraperitoneal Chemotherapy (HIPEC) With Raltitrexed or Oxaliplatin Versus no HIPEC in Locally Advanced Colorectal Cancer (APEC Study)

NCT02965248 is registered in ClinicalTrials.gov with Fudan University as lead sponsor.

NCT NCT02965248
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02965248 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicenter, Randomized Controlled Trial Designed to Evaluate the Efficacy and Safety of Adjuvant Hyperthermic Intraperitoneal Chemotherapy (HIPEC) With Raltitrexed or Oxaliplatin Versus no HIPEC in Locally Advanced Colorectal Cancer (APEC Study)
Lead sponsor
Fudan University
Phase
Phase 3
Overall status
Unknown status
Start date
November 30, 2016
Completion date
November 30, 2023
Enrollment
147 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

locally advanced colorectal cancer